Palvella Therapeutics: director George M Jenkins sold 27,500 shares

What happened

• George M Jenkins, a director of Palvella Therapeutics, sold a total of 27,500 shares in open-market or private sales on Oct 12–14, 2026. Prices reported in the filing ranged from $121.14 to $136.44 per share, and total proceeds were $3,579,474.

Key details

• Transaction dates and totals by date:
  • Oct 12, 2026: 13,152 shares for $1,758,330.
  • Oct 13, 2026: 7,174 shares for $935,231.
  • Oct 14, 2026: 7,174 shares for $885,913.
• Shares owned after the transactions: not reported in the filing.
• Footnotes of note:
  • The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on Jun 12, 2026; the plan was adopted during an open trading window and reviewed under the issuer's insider trading policy (footnote F1).
  • Multiple footnotes (F2–F18) state the prices shown are weighted averages and give the ranges of prices at which the shares were sold; the reporting person will provide a breakdown on request. Footnote F19 references Eagles Mere Air Museum Foundation.
• Form 4 filed Oct 14, 2026 (period of report Oct 12, 2026).

Why it may matter

• These were reported as open-market or private sales under a Rule 10b5-1 plan, not option exercises or gifts.
• A filing does not show why the insider traded or why the company acted.